Progression of HPV infection to detectable cervical lesions or clearance in adult women: Analysis of the control arm of the VIVIANE study

Individual detection of 14 high risk human papilloma virus genotypes by the PapType test for the prediction of high grade cervical lesions

(2014) Jack Cuzick et al.   JOURNAL OF CLINICAL VIROLOGY

Risk of Newly Detected Infections and Cervical Abnormalities in Women Seropositive for Naturally Acquired Human Papillomavirus Type 16/18 Antibodies: Analysis of the Control Arm of PATRICIA

(2014) Xavier Castellsagué et al.   JOURNAL OF INFECTIOUS DISEASES

Efficacy, safety, and immunogenicity of the human papillomavirus 16/18 AS04-adjuvanted vaccine in women older than 25 years: 4-year interim follow-up of the phase 3, double-blind, randomised controlled VIVIANE study

(2014) S Rachel Skinner et al.   LANCET

Triage of HR-HPV Positive Women with Minor Cytological Abnormalities: A Comparison of mRNA Testing, HPV DNA Testing, and Repeat Cytology Using a 4-Year Follow-Up of a Population-Based Study

(2014) Maria Persson et al.   PLoS One

Redetection of Cervical Human Papillomavirus Type 16 (HPV16) in Women With a History of HPV16

(2013) Anna-Barbara Moscicki et al.   JOURNAL OF INFECTIOUS DISEASES

No Evidence for Synergy Between Human Papillomavirus Genotypes for the Risk of High-Grade Squamous Intraepithelial Lesions in a Large Population-Based Study

(2013) Nicolas Wentzensen et al.   JOURNAL OF INFECTIOUS DISEASES

Natural History of Progression of HPV Infection to Cervical Lesion or Clearance: Analysis of the Control Arm of the Large, Randomised PATRICIA Study

(2013) Unnop Jaisamrarn et al.   PLoS One

Prevalence and risk factors for cervical HPV infection and abnormalities in young adult women at enrolment in the multinational PATRICIA trial

(2012) Edith Roset Bahmanyar et al.   GYNECOLOGIC ONCOLOGY

Differences in human papillomavirus type distribution in high-grade cervical intraepithelial neoplasia and invasive cervical cancer in Europe

(2012) Wiebren A. Tjalma et al.   INTERNATIONAL JOURNAL OF CANCER

A population-based study of human papillomavirus genotype prevalence in the United States: Baseline measures prior to mass human papillomavirus vaccination

(2012) Cosette M. Wheeler et al.   INTERNATIONAL JOURNAL OF CANCER

Evidence Regarding Human Papillomavirus Testing in Secondary Prevention of Cervical Cancer

(2012) Marc Arbyn et al.   VACCINE

Incident Cervical HPV Infections in Young Women: Transition Probabilities for CIN and Infection Clearance

(2011) R. P. Insinga et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Clustering of Multiple Human Papillomavirus Infections in Women From a Population-Based Study in Guanacaste, Costa Rica

(2011) Salvatore Vaccarella et al.   JOURNAL OF INFECTIOUS DISEASES

Human Papillomavirus Infection with Multiple Types: Pattern of Coinfection and Risk of Cervical Disease

(2011) Anil K. Chaturvedi et al.   JOURNAL OF INFECTIOUS DISEASES

One virus, one lesion-individual components of CIN lesions contain a specific HPV type

(2011) Wim Quint et al.   JOURNAL OF PATHOLOGY

Concurrent Infection with Multiple Human Papillomavirus Types: Pooled Analysis of the IARC HPV Prevalence Surveys

(2010) S. Vaccarella et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Human Papillomavirus Infection and Reinfection in Adult Women: the Role of Sexual Activity and Natural Immunity

(2010) H. Trottier et al.   CANCER RESEARCH

Cervical Human Papillomavirus Prevalence in 5 Continents: Meta‐Analysis of 1 Million Women with Normal Cytological Findings

(2010) Laia Bruni et al.   JOURNAL OF INFECTIOUS DISEASES

Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study

(2010) Silvia de Sanjose et al.   LANCET ONCOLOGY

Cervical Carcinoma and Sexual Behavior: Collaborative Reanalysis of Individual Data on 15,461 Women with Cervical Carcinoma and 29,164 Women without Cervical Carcinoma from 21 Epidemiological Studies

(2009)   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Cigarette smoking is an independent risk factor for cervical intraepithelial neoplasia in young women: A longitudinal study

(2009) Stuart Collins et al.   EUROPEAN JOURNAL OF CANCER

Human Papillomavirus Genotype Distributions: Implications for Vaccination and Cancer Screening in the United States

(2009) Cosette M. Wheeler et al.   JNCI-Journal of the National Cancer Institute

Risk of Human Papillomavirus–Associated Cancers Among Persons With AIDS

(2009) Anil K. Chaturvedi et al.   JNCI-Journal of the National Cancer Institute

Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24–45 years: a randomised, double-blind trial

(2009) Nubia Muñoz et al.   LANCET

Estimating Progression Rates for Human Papillomavirus Infection From Epidemiological Data

(2009) Mark Jit et al.   MEDICAL DECISION MAKING

Persistent Human Papillomavirus Infection and Cervical Neoplasia: A Systematic Review and Meta-Analysis

(2008) J. Koshiol et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Age-dependent prevalence of 14 high-risk HPV types in the Netherlands: implications for prophylactic vaccination and screening

(2008) V M H Coupé et al.   BRITISH JOURNAL OF CANCER